首頁 > 市場調查報告書 > 醫療設備

體外診斷

歐洲免疫診斷市場預測至 2030 年 - 區域分析 - 按產品（酵素連結免疫吸附測定、化學發光免疫測定、放射免疫測定等）、臨床適應症和最終用戶

市場調查報告書

商品編碼

1402521

歐洲免疫診斷市場預測至 2030 年 - 區域分析 - 按產品（酵素連結免疫吸附測定、化學發光免疫測定、放射免疫測定等）、臨床適應症和最終用戶

Europe Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

出版日期: 2023年11月07日 | 出版商:

The Insight Partners | 英文 209 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲免疫診斷市場預計將從2023年的61.3185億美元成長到2030年的100.9803億美元。預計2023年至2030年CAGR為7.4%。

傳染病率的增加推動了歐洲免疫診斷市場

由病毒、真菌、細菌、寄生蟲或其有毒產物等感染原引起的幾種不斷成長的傳染病的診斷和治療，免疫診斷測試的處方數量激增，例如補體結合、沉澱測試、凝集測試、線印跡分析、蛋白質印跡分析、酵素免疫分析(EIA) 和免疫螢光測試。人類免疫缺乏病毒（HIV）仍然是世界範圍內的一個主要公共衛生問題。此外，結核病 (TB)、COVID-19 和其他院內感染 (HAIs) 需要進行免疫診斷測試。

結核病已成為第 13 大死因，也是僅次於 COVID-19 的第二大傳染病殺手。 2020 年，全球有 150 萬人死於結核病，估計有 1,000 萬人受到影響，其中包括 560 萬名男性、330 萬名女性和 110 萬名兒童。

據 Worldometer 稱，全球報告了數百萬人因 COVID-19 大流行而死亡。它給醫療保健系統帶來了壓力，並增加了對免疫診斷測試的需求。

診斷在確定合適的醫療方法方面發揮著至關重要的作用。免疫診斷有助於診斷嚴重影響免疫系統的疾病。因此，傳染病盛行率的上升導致對免疫診斷產品的需求激增。

歐洲免疫診斷市場概況

龐大的老年人口極大地推動了德國免疫診斷市場的發展。根據聯合國人口資料，每20 名德國人中就有1 人年齡在80 歲以上，預計到2050 年，這一數字將增加到每20 人中就有6 人。患慢性疾病的風險，如心血管疾病(CVD)、糖尿病、和神經血管疾病，隨著年齡的成長而增加。根據羅伯特·科赫研究所2023年9月發布的德國癌症登記資料中心（ZfKD）估計，2019年德國有502,655人患有癌症，其中女性234,925人，男性267,730人。據估計，由於生活方式的改變、肥胖、不健康的習慣等，癌症的流行可能會持續下去。德國最常見的癌症是乳癌、攝護腺癌、大腸癌（大腸癌）、肺癌和膀胱癌。這五種癌症約佔德國所有新診斷癌症的 57%。因此，癌症盛行率的增加可能會推動對免疫診斷的需求。

德國是僅次於美國的世界領先的醫療生物技術國家。與新冠疫情爆發前的 2018 年相比，2020 年德國生物技術產業顯著成長。過去幾年，一些領域的正面市場趨勢已加速；根據BIOCOM符合OECD標準的調查顯示，2020年德國生技產業的營業額成長了近50%。老牌企業的存在和新創企業的出現肯定了產業實力。工業、政府和研究部門的蓬勃發展依賴強大的市場基礎。德國擁有許多歐洲生物技術公司、世界一流的研究基礎設施和國際知名科學家，已牢固確立了其國際醫療生物技術中心的地位。德國生物技術公司推出了歐洲藥品管理局批准的首個 COVID-19 檢測和疫苗接種，成為 mRNA 技術的全球領導者。這些發展促進了免疫診斷技術的進步。因此，生物技術產業的崛起可能會提振該國的免疫診斷市場。

歐洲免疫診斷市場收入及 2030 年預測（百萬美元）

歐洲免疫診斷市場細分

歐洲免疫診斷市場分為產品、臨床適應症、最終用戶和國家。

根據產品，歐洲免疫診斷市場分為酵素連結免疫吸附測定（ELISA）、化學發光免疫測定（CLIA）、放射免疫測定（RIA）等。 2023年，酵素連結免疫吸附測定（ELISA）領域在歐洲免疫診斷市場佔據最大佔有率。化學發光免疫分析 (CLIA) 領域進一步細分為維生素 D 分析市場、HIV 檢測市場、HIV a/ab 組合分析市場和其他測試。

根據臨床適應症，歐洲免疫診斷市場分為傳染病、肝炎+愛滋病、內分泌、胃腸道、代謝等。 2023年，傳染病領域在歐洲免疫診斷市場中佔最大佔有率。傳染病細分為 COVID-19、結核病、萊姆病、感染管理、寨卡病毒、密螺旋體、火炬、麻疹和腮腺炎、水痘帶狀皰疹病毒和 EB 病毒。內分泌科進一步細分為高血壓、生長、糖尿病、甲狀腺和生殖內分泌。

根據最終用戶，歐洲免疫診斷市場分為醫院、診所、診斷實驗室、學術和研究機構等。 2023年，醫院細分市場在歐洲免疫診斷市場中佔據最大佔有率。

根據國家/地區，歐洲免疫診斷市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2023年，德國市場在歐洲免疫診斷市場佔有最大佔有率。

雅培實驗室；生物梅里埃公司；丹納赫公司； DiaSorin SpA； F.霍夫曼-拉羅氏有限公司；珀金埃爾默公司；深圳邁瑞生物醫療電子有限公司；西門子醫療保健有限公司；斯瓦爾生命科學公司；和 Thermo Fisher Scientific Inc 是歐洲免疫診斷市場上一些領先的公司。

概述
按臨床適應症分類的歐洲免疫診斷市場佔有率 - 2022 年和 2030 年 (%)
傳染性疾病：
- 概述
  - 新冠肺炎
  - 結核
  - 萊姆病
  - 感染管理
  - 寨卡病毒
  - 密螺旋體屬
  - 火炬
  - 麻疹和腮腺炎
  - VZV
  - EB病毒
肝炎+愛滋病毒：
- 概述
胃腸道
- 概述
代謝紊亂
- 概述
內分泌科
- 概述
- 高血壓
  - 概述
- 生長
  - 概述
- 糖尿病
  - 概述
- 甲狀腺
  - 概述
- 生殖內分泌學
  - 概述
其他
- 概述

第 9 章：歐洲免疫診斷市場分析 - 最終用戶

概述
按最終用戶分類的歐洲免疫診斷市場佔有率 - 2022 年和 2030 年 (%)
醫院
- 概述
診所
- 概述
診斷實驗室
- 概述
學術及研究機構
- 概述
其他
- 概述

第 10 章：歐洲免疫診斷市場 - 2030 年收入與預測 - 國家分析

概述

第 11 章：歐洲免疫診斷市場 - 產業格局

概述
無機成長策略
- 概述
有機成長策略
- 概述

第 12 章：公司簡介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corp
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
bioMerieux SA
Svar Life Science AB
Siemens Healthcare GmbH

第 13 章：附錄

關於 Insight Partners
專業術語

簡介目錄圖表

Product Code: BMIRE00027867

The Europe immunodiagnostics market is expected to grow from US$ 6,131.85 million in 2023 to US$ 10,098.03 million by 2030. It is estimated to grow at a CAGR of 7.4% from 2023 to 2030.

Increasing Prevalence of Infectious Diseases Drive Europe Immunodiagnostics Market

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests. Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide. Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.

TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.

According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.

Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.

Europe Immunodiagnostics Market Overview

The huge geriatric population is significantly driving the market for immunodiagnostics in Germany. According to the UN population data, 1 out of 20 Germans is aged above 80 years, and the number is expected to increase to 6 out of 20 by 2050. The risk of developing chronic diseases, such as cardiovascular diseases (CVDs), diabetes, and neurovascular disorders, increases with age. According to the estimates of the German Centre for Cancer Registry Data (ZfKD) published by the Robert Koch Institute in September 2023, in Germany, 502,655 people had cancer in 2019, among which 234,925 were women and 267,730 were men. It is estimated that the prevalence of cancer is likely to continue owing to lifestyle changes, obesity, unhealthy habits, and more. The most common cancers in Germany are breast, prostate, colorectum (large bowel), lung, and bladder cancer. These five cancer types accounted for about 57% of all new cancer diagnoses in Germany. Thus, the increasing prevalence of cancer is likely to propel the demand for immunodiagnostics.

Germany is the leading medical biotech nation in the world after the US. In 2020, the German biotechnology sector grew significantly compared to the pre-COVID year 2018. The positive market trend has accelerated in the last few years in some areas; and according to the OECD-compliant survey by BIOCOM, the German biotechnology industry's turnover increased by almost 50% in 2020. The presence of long-established companies and the emergence of start-ups affirmed the industrial strength. Industry, government, and research sectors thrive on strong market foundations. With many European biotech companies, world-class research infrastructure, and internationally renowned scientists, Germany has firmly established itself as an international medical biotechnology hub. German biotech companies emerged as global leaders in mRNA technologies by introducing the first COVID-19 test and vaccination, approved by the European Medicines Agency. Such developments have encouraged enhanced technological advancements for immunodiagnostics. Thus, the rising biotechnology sector will likely boost the country's immunodiagnostics market.

Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Immunodiagnostics Market Segmentation

The Europe immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the Europe immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the Europe immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the Europe immunodiagnostics market is segmented into infectious diseases, hepatitis+hiv, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the Europe immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the Europe immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the Europe immunodiagnostics market.

Based on country, the Europe immunodiagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered the largest share in the Europe immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe immunodiagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunodiagnostics market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Immunodiagnostics Market - by Product
- 1.3.2 Europe Immunodiagnostics Market - by Clinical Indication
- 1.3.3 Europe Immunodiagnostics Market - by End User
- 1.3.4 Europe Immunodiagnostics Market - by Country

2. Europe Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion

5. Europe Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
- 5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
- 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
- 5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - Europe Analysis

6.1 Europe Immunodiagnostics Market Revenue Forecast and Analysis

7. Europe Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 Europe Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
- 7.3.1 Overview
- 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
- 7.4.1 Overview
- 7.4.2 Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Vitamin D Assay
  - 7.4.3.1 Overview
  - 7.4.3.2 Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 HIV Detection
  - 7.4.4.1 Overview
  - 7.4.4.2 HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 HIV Ag/Ab Combo assay
  - 7.4.5.1 Overview
  - 7.4.5.2 HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Other Tests
  - 7.4.6.1 Overview
  - 7.4.6.2 Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
- 7.5.1 Overview
- 7.5.2 Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 COVID-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Tuberculosis
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Lyme
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Infection Management
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Zika
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.6 Treponema
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.7 TORCH
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.8 Measles and Mumps
    - 8.3.2.8.1 Overview
    - 8.3.2.8.2 Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.9 VZV
    - 8.3.2.9.1 Overview
    - 8.3.2.9.2 VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.10 EBV
    - 8.3.2.10.1 Overview
    - 8.3.2.10.2 EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
- 8.4.1 Overview
- 8.4.2 Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
- 8.5.1 Overview
- 8.5.2 Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
- 8.6.1 Overview
- 8.6.2 Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
- 8.7.1 Overview
- 8.7.2 Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.3 Hypertension
  - 8.7.3.1 Overview
  - 8.7.3.2 Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.4 Growth
  - 8.7.4.1 Overview
  - 8.7.4.2 Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.5 Diabetes
  - 8.7.5.1 Overview
  - 8.7.5.2 Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.6 Thyroid
  - 8.7.6.1 Overview
  - 8.7.6.2 Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.7 Reproductive Endocrinology
  - 8.7.7.1 Overview
  - 8.7.7.2 Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Europe Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Clinics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Europe Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview

11. Europe Immunodiagnostics Market -Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DiaSorin SpA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Danaher Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PerkinElmer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Svar Life Science AB
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. UK Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. UK Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. France Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. France Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Italy Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Europe immunodiagnostics market
Table 38. Recent Organic Growth Strategies in the Europe immunodiagnostics market
Table 39. Glossary of Terms, Europe Immunodiagnostics Market

List Of Figures

Figure 1. Europe Immunodiagnostics Market Segmentation
Figure 2. Europe Immunodiagnostics Market, by Country
Figure 3. Europe Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Europe Immunodiagnostics Market
Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Europe Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. Europe Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: Europe Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. Europe: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. UK: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)